- Industry: Pharmaceuticals
- Founded: 1983
- Country: Canada
- CEO: J Michael Pearson
- Website: www.valeant.com
Profile
Valeant Pharmaceuticals International, Inc.,
formerly Biovail Corporation, is a multinational, specialty
pharmaceutical company that develops, manufactures and markets a range
of pharmaceutical products. The Company operates in five business
segments: U.S. Neurology and Other, U.S. Dermatology, Canada and
Australia, Branded Generics - Europe and Branded Generics -Latin
America.
Within its U.S. Dermatology
segment and Branded Generic - Europe segment the Company generates
service revenue from contract services in the areas of dermatology and
topical medication. On March 12, 2012, it acquired a 19.9% minority
equity investment in Pele Nova Biotecnologia S.A. In September 2012, the
Company acquired Visudyne, which is used to treat abnormal growth of
leaky blood vessels in the eye caused by wet age-related macular
degeneration. On December 7, 2012, the Company acquired Medicis
Pharmaceutical Corporation. In February 2013, it acquired Natur Produkt
International, JSC.